Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-30T15:08:20.286Z Has data issue: false hasContentIssue false
  • English
  • Français

The Increased Susceptibility of Women to Multiple Sclerosis

Published online by Cambridge University Press:  18 September 2015

P. Duquette ,
J. Pleines ,
M. Girard ,
L. Charest ,
M. Senecal-Quevillon  and
C. Masse
P. Duquette*
Affiliation:
Hôpital Notre-Dame, Montreal
J. Pleines
Affiliation:
Hôpital Notre-Dame, Montreal
M. Girard
Affiliation:
Hôpital Notre-Dame, Montreal
L. Charest
Affiliation:
Hôpital Notre-Dame, Montreal
M. Senecal-Quevillon
Affiliation:
Hôpital Notre-Dame, Montreal
C. Masse
Affiliation:
Hôpital Notre-Dame, Montreal
*
Hôpital Notre-Dame, 1560 est, rue Sherbrooke, Montreal, P.Q., Canada H2L 4MI
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Many diseases with an auto-immune etiology have a skewed sex distribution. In the majority of instances, women are affected more frequently than men. A review of population studies demonstrates that the preponderance of women in multiple sclerosis (MS) is almost constant. We show that this preponderance is further increased in early as well as in late-onset cases, in familial cases as well as in MS twin pairs and that the HLA-DR2 allele, which has been associated with MS in Caucasian populations, is significantly more frequent in women than in men with MS. “Rules” have been established for multifactorial diseases; MS contravenes most of those rules. The skewed sex distribution in MS could be attributed to the known hormonal and gender influences on the immune response, as well as to genetic influences.

Type
Articles
Information
Canadian Journal of Neurological Sciences , Volume 19 , Issue 4 , November 1992 , pp. 466 - 471
Copyright
Copyright © Canadian Neurological Sciences Federation 1992

References

REFERENCES

1.Francis, GS, Antel, JP, Duquette, P.Inflammatory demyelinating diseases of the CNS. In: Bradley, WG, Daroff, B, Fenichel, GM, Marsden, CD, eds. Neurology in Clinical Practice. Boston: Butterworth Publishers, 1990; 1150.Google Scholar
2.Schuurs, AH, Verheul, HA.Effects of gender and sex steroids on the immune response. J Steroids Biochem 1990; 35(2): 157–172.CrossRefGoogle ScholarPubMed
3.Ward, MM, Studenski, S.Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990; 17(2): 220–224.Google Scholar
4.Blumenthal, HT, Perlstein, IB.The aging thyroid. I. A description of lesions and an analysis of their age and sex distribution. J Am GeriatrSoc 1987; 35(9): 843–854.CrossRefGoogle Scholar
5.Khan, MA, Yamashita, TS, Reynolds, TL, et al. HLA-DR4 genotype frequency and gender effect in familial rheumatoid arthritis. Tissue Antigens 1988; 31(5): 254–258.CrossRefGoogle ScholarPubMed
6.Rey, RD, Sanz, OP, Fernandez, JM, et al. Diagnosis and treatment of myasthenia gravis: study of an inpatient population. Arq Neuropsiquiatr 1990; 48(3): 270–278.CrossRefGoogle ScholarPubMed
7.Gran, JT, Husby, G, Hordick, M.Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis 1985; 44: 359–367.CrossRefGoogle Scholar
8.Michel, CJ.Epidemiology of vasculitis. Rheumat Dis Clin of N Am 1990; 16(2): 261–268CrossRefGoogle Scholar
9.Roman, GC, Spencer, PS, Schoenberg, BS, et al. Tropical spastic paraparesis in the Seychelles Islands: a clinical and case-control neuroepidemiologic study. Neurology 1987; 37: 1323–1328.CrossRefGoogle ScholarPubMed
10.Childs, B, Scriver, CR.Age at onset and causes of disease. Perspect Biol Med 1986; 29: 437–460.Google Scholar
11.Alter, M, et al. Multiple sclerosis in Israel: prevalence among immigrants and native inhabitants. Arch Neurol 1962; 7: 253–263.CrossRefGoogle ScholarPubMed
12.Bennett, P, et al. Survey of persons with MS in Ottawa; 1974-1975. Can J Public Health 1977; 68: 141–147.Google Scholar
13.Brady, R, et al. Multiple sclerosis in the Republic of Ireland. Irish Med J 1977; 70: 500–506.Google ScholarPubMed
14.Chipman, M: Multiple sclerosis in Houston, Texas; 1954-1959. Acta Neurol Scand 1966; 42 (Suppl 19): 77–82.CrossRefGoogle ScholarPubMed
15.Dean, G, et al. Annual incidence, prevalence and mortality of multiple sclerosis in white South-African born and white immigrants to South Africa. Br Med J 1967; 2: 724–730.CrossRefGoogle ScholarPubMed
16.Dean, G, et al. Multiple sclerosis among immigrants in Greater London. Br Med J 1976; 1: 861–864.CrossRefGoogle ScholarPubMed
17.Detels, R, et al. Evidence of lower susceptibility to multiple sclerosis in Japanese Americans. Am J Epidemiol 1977; 105: 303–310.CrossRefGoogle ScholarPubMed
18.Gallow, M, et al. Epidemiologie de la sclérose en plaques en Bretagne. Presse Médicale 1983; 12: 995–999.Google Scholar
19.Granieri, E, Rosati, G.Italy, a medium or high risk area for multiple sclerosis? An epidemiologic study in Barbagna, Sardinia, southern Italy. Neurology 1982; 32: 466–472.CrossRefGoogle ScholarPubMed
20.Granieri, E, et al. The frequency of multiple sclerosis in Mediterranean Europe. An incidence and prevalence study in Barbagna, Sardinia, insular Italy. Acta Neurol Scand 1983; 68: 84–89.CrossRefGoogle Scholar
21.Granieri, E, et al. The frequency of multiple sclerosis in Italy — a descriptive study in Ferrano. Ann Neurol 1985; 17: 80–84.CrossRefGoogle Scholar
22.Hader, WJ.Prevalence of multiple sclerosis in Saskatoon. Can Med Assoc J 1982; 127: 295–297.Google ScholarPubMed
23.Hoffman, RE, et al. Increased incidence and prevalence of multiple sclerosis in Los Alamos County, New Mexico. Neurology 1984; 34: 1457–1492.Google Scholar
24.Kinnunen, E.Multiple sclerosis in Finland, evidence of increasing and uneven geographic distribution. Neurology 1984; 34: 457–461.CrossRefGoogle ScholarPubMed
25.Kurtzke, JF, Hyllested, K.Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features. Ann Neurol 1979; 5: 6–21.CrossRefGoogle ScholarPubMed
26.Kurtzke, JF, et al. Multiple sclerosis in Iceland. I. Evidence of a postwar epidemic. Neurology 1982; 32: 143–150.CrossRefGoogle ScholarPubMed
27.Larsen, JT, et al. Western Norway — a high risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland, Norway. Neurology 1984; 34: 1202–1207.CrossRefGoogle ScholarPubMed
28.McCall, MG, et al. Frequency of multiple sclerosis in three Australian cities: Perth, Newcastle and Mobart. J Neurol Neurosurg Psychiatry 1968; 31: 1–9.CrossRefGoogle Scholar
29.McCall, MG, et al. The frequency of multiple sclerosis in Western Australia. Acta Neurol Scand 1969; 45: 151–165.CrossRefGoogle ScholarPubMed
30.Oltedel, SI.Multiple sclerosis in Vestfeld, Norway. Acta Neurol Scand 1966; 42 (Suppl 19): 19–26.Google Scholar
31.Percy, AK, et al. Multiple sclerosis in Rochester, Minnesota — a sixty year appraisal. Arch Neurol 1971; 25: 105–111.CrossRefGoogle Scholar
32.Poser, S.Multiple sclerosis — an analysis of 812 cases by means of electronic data processing. Berlin: Springer Verlag, 1978.Google Scholar
33.Presthus, J.Multiple sclerosis in More og Romsdal County, Norway. Acta Neurol Scand 1966; 42 (Suppl 19): 12–18.CrossRefGoogle ScholarPubMed
34.Rischbreth, RH.The prevalence of disseminated sclerosis in South Australia. Med J Aust 1966; 1: 774–776.CrossRefGoogle Scholar
35.Saint, EG, Sadka, M.The incidence of multiple sclerosis in Western Australia. Med J Aust 1962; 2: 249–250.CrossRefGoogle Scholar
36.Sheperd, DI, Dourine, AW.Prevalence of multiple sclerosis in north-east Scotland. Br Med J 1978; 2: 314–316.CrossRefGoogle Scholar
37.Stazio, A, et al. Multiple sclerosis in Winnipeg, Manitoba — methodological considerations of epidemiological survey: ten years follow-up on a community-wide study and population resurvey. J Chronic Dis 1964; 17: 415–438.CrossRefGoogle Scholar
38.Stazio, A, et al. Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada. Follow-up of a previous survey in New Orleans and comparison between the patient populations of the two communities. J Chronic Dis 1967; 20: 311–332.CrossRefGoogle ScholarPubMed
39.Sutherland, M.Observations on the prevalence of multiple sclerosis in northern Scotland. Brain 1956; 1979: 455–483.Google Scholar
40.Alter, M, Harsche M, Anderson, VE, et al. Genetic association of multiple sclerosis and HL-A determinants. Neurology 1979; 29: 1354–1360.Google Scholar
41.Barroche, G, Perrier, P, Raffoux, C, et al. HLA et sclérose en plaques familiale. Rev Neurol (Paris) 1986; 142(10): 738–745.Google Scholar
42.Bird, TD.Apparent familial multiple sclerosis in three generations. Arch Neurol 1975; 32: 414–416.CrossRefGoogle ScholarPubMed
43.Drachman, DA, Davidson, WC, Mittal, KK.Histocompatibility (HL-A) factors in familial multiple sclerosis. Arch Neurol 1976; 33: 406–413.CrossRefGoogle ScholarPubMed
44.Eldridge, R, McFarland, H, Sever, J, et al. Familial multiple sclerosis: clinical histocompatibility and viral serological studies. Ann Neurol 1978; 3: 72–80.CrossRefGoogle ScholarPubMed
45.Ekbom, K.Familial multiple sclerosis associated with narcolepsy. Arch Neurol 1975; 15: 337–416.CrossRefGoogle Scholar
46.Hens, L, Carton, H.HL-A determinants and familial multiple sclerosis: HL-A typing of 13 families with at least two affected members. Tissue Antigens 1978; 11: 75–80.CrossRefGoogle ScholarPubMed
47.Olsson, JE, Moller, E, Link, H.HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol 1976; 33: 808–812.CrossRefGoogle ScholarPubMed
48.Pratt, RTC, Compston, ND, McAlpine, D.The familial incidence of disseminated sclerosis and its significance. Brain 1951; 74: 191–232.CrossRefGoogle ScholarPubMed
49.Stewart, GJ, McLeod, JG, Basten, A, et al. HLA family studies and multiple sclerosis: a common gene, dominantly expressed. Hum Immunol 1981; 3: 13–29.CrossRefGoogle ScholarPubMed
50.Turpin, JC, Dubois, D, Delasnerie-Lauprêtre, N.La prédisposition familiale à la sclérose en plaques. Rev Neurol (Paris) 1986; 142(5): 509–516.Google Scholar
51.Visscher, BR, Detels, R, Dudley, J, et al. Genetic susceptibility to multiple sclerosis. Neurology 1979; 29: 1354–1360.CrossRefGoogle ScholarPubMed
52.Bobowick, AR, Kurtzke, JF, Brody, JA, et al. Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology 1978; 28: 978–987.CrossRefGoogle ScholarPubMed
53.Cendrowski, WS.Multiple sclerosis in twins and other relatives. Acta Neurol Scand 1973; 49: 552–556.CrossRefGoogle ScholarPubMed
54.Currier, RD, Eldridge, R.Possible risk factors in multiple sclerosis as found in a national twin study. Arch Neurol 1982; 39: 140–144.CrossRefGoogle Scholar
55.Ebers, GC, Bulman, DE, Sadovnick, DA, et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986; 315: 1638–1642.CrossRefGoogle ScholarPubMed
56.Kinnunen, E, et al. Multiple sclerosis in a nationwide series of twins. Neurology 1987; 37(10): 1627–1629.CrossRefGoogle Scholar
57.Williams, A, Eldridge, R, McFarland, H, et al. Multiple sclerosis in twins. Neurology 1980; 30: 1139–1147.CrossRefGoogle ScholarPubMed
58.Duquette, P, Girard, M, Pleines, J.Aspects of the women predominance in multiple sclerosis 1987; 111: 359–363.Google Scholar
59.Plascencia, A, Ostfeld, AM, Gruber, SB.Effects of sex on differences in awareness, treatment and control of high blood pressure. Am J Prev Med 1988; 4(6): 315–326.CrossRefGoogle Scholar
60.Stewart, WF, Celentano, DD, Linet, MS.Disability, physician consultation and use of prescription medications in a population-based study of headache. Biomed Pharmacother 1989; 43(10): 711–718.CrossRefGoogle Scholar
61.Noseworthy, J, Paty, D, Wonnacott, T, et al. Multiple sclerosis after age 50. Neurology (Cleveland) 1983; 33: 1537–1544.CrossRefGoogle ScholarPubMed
62.Sadownick, AD, Bulman, DE, Hashimoto, L, et al. The influence of gender on the susceptibility to multiple sclerosis in sibships. Arch Neurol 1991; 48: 586–588.CrossRefGoogle Scholar
63.Weitkamp, LR.Multiple sclerosis susceptibility: interaction between sex and HLA. Arch Neurol 1983; 40: 399–401.CrossRefGoogle ScholarPubMed
64.Kurtzke, JF, Beebe, GW, Norman, JE.Epidemiology of multiple sclerosis in U.S. veterans. I. Race, sex and geographic distribution. Neurology (NY) 1979; 29(9): 1228–1235.CrossRefGoogle ScholarPubMed
65.Myrianthopoulos, NC.Genetic aspects of multiple sclerosis. In: Koestier, JC, ed. Handbook of Clinical Neurology: Demyelinating Diseases. New York: Elsevier, 1985; 3(47): 10: 289–317.Google Scholar
66.Compston, A, Ebers, G.The genetics of multiple sclerosis. In: Cook, SD, ed. Handbook of multiple sclerosis. New York: Marcel Dekker, Inc, 1990; 25–39.Google Scholar
67.Charest, L, Duquette, P.Interaction between sex and HLA in a population study. Arch Neurol 1984; 41: 704.CrossRefGoogle ScholarPubMed
68.Poskanzer, DC, Terasaki, PI, Prenney, LB, et al. Multiple sclerosis in the Orkney and Shetland Islands. III. Histocompatibility determinants. J Epidemiol Commun Health 1980; 34: 253–257.CrossRefGoogle ScholarPubMed
69.Calin, A, Berrnett, PH, Jupiter, J, et al. HLA B-27 and sacro-iliitis in Pima Indians: association in males only. J Rheumatol 1977; 3 (Suppl): 44–48.Google Scholar
70.Pirskanen, R.Genetic associations between myasthenia gravis and the HLA system. J Neurol Neurosurg Psychiatry 1976; 39: 23–33.CrossRefGoogle Scholar
71.Bell, DA, Rigby, R, Stiller, CR, et al. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset and sex. J Rheumatol 1984; 11: 475–479.Google ScholarPubMed
72.Lewis, GP.Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull 1983; 39: 243–248.CrossRefGoogle ScholarPubMed
73.Van Lambalgen, R, Sanders, EA, D’Amaro, J.Sex distribution, age at onset and HLA profiles in two types of multiple sclerosis. A role for sex hormones and microbial infections in the development of autoimmunity? J Neurol Sci 1986; 76: 13–21.CrossRefGoogle ScholarPubMed
74.Devor, EJ.Untying the gordian knot: the genetics of Tourette syndrome. J Nerv Ment Dis 1990; 178: 669–679.CrossRefGoogle ScholarPubMed